The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex several-stage organic process. Initial routes focused on protein fragment coupling, utilizing solid-phase https://jadaplhn960961.ssnblog.com/39406393/synthesis-and-investigation-implementations-of-retatrutide